HMD 21.7% 1.8¢ heramed limited

Ann: Mayo Clinic clinical study to evaluate HeraBEAT Plus, page-2

  1. 1,071 Posts.
    lightbulb Created with Sketch. 179
    great milestone and achievement, having mayo clinic on are side. Mayo Clinic will initiate a clinical study to evaluate HMD’s HeraBEAT Plus solution.
    This study will recruit low-risk expectant mothers from the Obstetrics and Gynecology Department at Mayo
    Clinic in Rochester, Minnesota. The overall study will be guided by an assessment of device functionality
    and user acceptability, as well as an evaluation of the impact of the device on expectant mother's
    perception of foetal well-being, as measured by standardized surveys.

    this will give more confidence for big orders and commercial disturbution deals

    great work HMD
    Last edited by Alby118: 10/02/20
 
watchlist Created with Sketch. Add HMD (ASX) to my watchlist
(20min delay)
Last
1.8¢
Change
-0.005(21.7%)
Mkt cap ! $11.39M
Open High Low Value Volume
2.2¢ 2.2¢ 1.8¢ $15.18K 742.0K

Buyers (Bids)

No. Vol. Price($)
1 499999 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 16562 2
View Market Depth
Last trade - 16.10pm 23/07/2024 (20 minute delay) ?
HMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.